Detalles de la búsqueda
1.
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).
Haematologica
; 100(2): 284-92, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25638805
2.
The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience.
Ann Hematol
; 88(9): 855-61, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19189105
3.
Initial Results of Peripheral-Blood Stem-Cell Mobilization, Collection, Cryopreservation, and Engraftment After Autologous Transplantation Confirm That the Capacity-Building Approach Offers Good Chances of Success in Critical Contexts: A Kurdish-Italian Cooperative Project at the Hiwa Cancer Hospital, Sulaymaniyah.
J Glob Oncol
; (4): 1-8, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29244631
4.
The Start-Up of the first Hematopoietic Stem Cell Transplantation Center in the Iraqi Kurdistan: a Capacity-Building Cooperative Project by the Hiwa Cancer Hospital, Sulaymaniyah, and the Italian Agency for Development Cooperation: an Innovative Approach.
Mediterr J Hematol Infect Dis
; 9(1): e2017031, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28512560
5.
Reversible cardiac dysfunction without myocytolysis related to all-trans retinoic acid administration during induction therapy of acute promyelocytic leukemia.
Ann Hematol
; 88(1): 91-2, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18633613
6.
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia.
J Clin Oncol
; 32(14): 1463-71, 2014 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24733807
7.
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.
Blood
; 110(7): 2316-23, 2007 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17581918
8.
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients.
Br J Haematol
; 138(2): 186-95, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17593025
9.
CMV infection and pneumonia in hematological malignancies.
J Infect Chemother
; 9(3): 265-7, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-14513398
Resultados
1 -
9
de 9
1
Próxima >
>>